Ubiqi provides a digital platform that uses passive mobile/device data and third party data to provide personalized feedback and disease tracking to help power "citizen science" experiments for patients. Their goal is to use aggregated anonymized data to help healthcare organizations understand patient behavior and response to therapies. Their business model involves partnerships with pharma, payers, providers, and disease management companies. They have shown early success with migraine patients and are seeking funding to further develop their platform and business.
Planning a Product launch ? Here is a guideline/template for Defining a Go To Market Strategy. The deck would be more apt for Technology Product / Solution launch. Feel free to download and customize the deck for your needs.
Looking to scale something up? Depending on how you're going after your market/ acquiring users, you may need to build a sales organization that's optimized for a top-down or bottom-up sales process (or perhaps both).
Watch the video overview at http://a16z.com/2015/03/06/go-to-market-bootcamp/ and then check out this slide deck, which shares some concrete tips and tools for accelerating time to market -- from the go-to-market experts at a16z, led by 'sales savant' Mark Cranney.
Because selling to enterprises is a lot like getting a bill passed through Congress: it can get stuck. And getting stuck -- or going down the wrong path -- can mean death to startups in a competitive market. Here's how to avoid that.
Provides practical tips on how to prepare to enter the marketplace with your product. Relevant for all start-ups that are still in a development phase and contemplating the various pieces that need to be in place for product launch.
Health Sensors & Big Data (Ignite SF version)Rachel Kalmar
Sensors are everywhere, and are playing an increasingly important role in our health, our environments, and our interactions with the world. We're moving from a world in which the problem is collecting enough data to a world where we need better tools to understand the data pouring in through the floodgates. How can we make this data actionable?
digital transformation trends in healthcare-industry-training-ppt.pptxSakshiChoudhary945750
Digital transformation in healthcare refers to the integration of digital technologies into various aspects of healthcare delivery to improve efficiency, accessibility, and quality of care. This transformation encompasses a wide range of technologies, including electronic health records (EHRs), telemedicine, wearable devices, artificial intelligence (AI), big data analytics, and more.
Planning a Product launch ? Here is a guideline/template for Defining a Go To Market Strategy. The deck would be more apt for Technology Product / Solution launch. Feel free to download and customize the deck for your needs.
Looking to scale something up? Depending on how you're going after your market/ acquiring users, you may need to build a sales organization that's optimized for a top-down or bottom-up sales process (or perhaps both).
Watch the video overview at http://a16z.com/2015/03/06/go-to-market-bootcamp/ and then check out this slide deck, which shares some concrete tips and tools for accelerating time to market -- from the go-to-market experts at a16z, led by 'sales savant' Mark Cranney.
Because selling to enterprises is a lot like getting a bill passed through Congress: it can get stuck. And getting stuck -- or going down the wrong path -- can mean death to startups in a competitive market. Here's how to avoid that.
Provides practical tips on how to prepare to enter the marketplace with your product. Relevant for all start-ups that are still in a development phase and contemplating the various pieces that need to be in place for product launch.
Health Sensors & Big Data (Ignite SF version)Rachel Kalmar
Sensors are everywhere, and are playing an increasingly important role in our health, our environments, and our interactions with the world. We're moving from a world in which the problem is collecting enough data to a world where we need better tools to understand the data pouring in through the floodgates. How can we make this data actionable?
digital transformation trends in healthcare-industry-training-ppt.pptxSakshiChoudhary945750
Digital transformation in healthcare refers to the integration of digital technologies into various aspects of healthcare delivery to improve efficiency, accessibility, and quality of care. This transformation encompasses a wide range of technologies, including electronic health records (EHRs), telemedicine, wearable devices, artificial intelligence (AI), big data analytics, and more.
gemiusAdMonitor is a periodic report prepared by Gemius. The source of data is the gemiusDirectEffect research, which is the leading online advertisement monitoring system in the CEE region.
gemiusAdMonitor presents a ranking of most popular online ad formats and a wide range of indicators for display campaigns. The report also describes the advertising activity within chosen sectors of online market such as: finance, telecommunication and other.
Implicit Concept Testing & 3 Keys to Broader Adoption of Consumer NeuroscienceSentient Decision Science
Sentient’s Dr. Aaron Reid joined implicit industry leaders, Dr. Rafal Ohme, and Dr. Cristina De Balanzo for a Warc Webinar about the “Latest Thinking on Implicit Testing.” Dr Reid discussed implicit concept testing and three keys to broader adoption of consumer neuroscience: sound science, application awareness, and market validation.
New Drug Opportunity Assessments Strat Planning For Future SuccessPharmacision LLC
Pharmaceutical Business Development, Marketing and Strategic Planning Groups need an early read on opportunities, but oftentimes don’t have time or budget for extensive market research.
Pharmacision presents a step by step opportunity assessment and valuation process through a case study format.
Benefits of employing this process:
Quickly weed out projects with very low probability of commercial success,
Construct a framework for deeper dive assessments to validate and refine assumptions when greater market knowledge is needed before making go/no go decisions, Support clinical development and commercialization strategic planning, Reduce overall costs.
There is a second digital revolution being played out by consumers, driven by the rapid adoption of smartphones and connected devices. As with the initial growth of the internet, many companies are being slow to react and are potentially risking their future success. This paper is a survival guide
Beyond Scaling Up: Universal Access to Effective Malaria Prevention and Treat...IDS
This presentation was given at the 'Beyond Scaling Up: Pathways to Universal Access' workshop which was held at the Institute of Development Studies, Brighton on the 24-25 May, 2010. This event was co-sponsored by the Future Health Systems Research Programme Consortium and the STEPS Centre. Mehra presented on the work of the Malaria Consortium.
Littmann stethescope all models,littmann stethoscope buy online delhi/indiaSurgicals Shoppeseo
Skytech Medical is engaged in manufacturing and distribution of medical equipment and surgical instruments in India. The parent company Continental Surgical was established in 1954.An experienced and well-trained staff handles an extensive range of medical supplies, which can broadly be classified into the following categories :
Surgical Instruments and Equipments
Operating and Examination Tables and Lights
Stainless Steel Operating Room Furniture
Electro Medical Equipment used in Operating Room, Diagnostics, Imaging
Physiotherapy, Pathology Laboratories, Neonatology, Cardiac Care, etc.
Medical, Surgical and Laboratory Consumables
Powder Coated and Stainless Steel Hospital Furniture
Rehabilitation, Mobility and Personal Home Care Devices
Skytech Medical & Surgical Devices.
3617, Netaji Subhash Marg, Darya Ganj
New Delhi-110002, India
Tel:- 91-11-43528106
http://surgicalshoppe.co.in
surgicalshoppeseo@gmail.com
Keynote presentation by Tim Riesterer, Chief Strategy and Marketing Officer of Corporate Visions to the BMA Phoenix / Arizona Technology Council 5th Annual Marketing Technology Summit August 22, 2013.
Tim presented a powerful session that taught the audience how to be more effective presenters, marketers and sales people.
Tim Riesterer is responsible for leading the strategic direction of Corporate Visions in thought leadership, positioning and product development. Tim has more than 20 years experience in Marketing and Sales. Prior to joining Corporate Visions, Tim co-founded Customer Message Management, LLC (CMM Group), where he was CEO until it was acquired by Corporate Visions in 2008. Before CMM Group, Tim was CMO and VP of Strategic Services for Ventaso. Additionally Tim was President and CEO of Brady Marketing Group and has worked in marketing, communication and sales support for world-class technology manufacturers such as Rockwell Automation and GE Medical Systems.
Tim is co-author of Customer Message Management: Increasing Marketing’s Impact on Selling (Thomson/AMA) and Conversations that Win the Complex Sale: Using Power Messaging to Create More Opportunities, Differentiate Your Solution, and Close More Deals (McGraw Hill).
gemiusAdMonitor is a periodic report prepared by Gemius. The source of data is the gemiusDirectEffect research, which is the leading online advertisement monitoring system in the CEE region.
gemiusAdMonitor presents a ranking of most popular online ad formats and a wide range of indicators for display campaigns. The report also describes the advertising activity within chosen sectors of online market such as: finance, telecommunication and other.
Implicit Concept Testing & 3 Keys to Broader Adoption of Consumer NeuroscienceSentient Decision Science
Sentient’s Dr. Aaron Reid joined implicit industry leaders, Dr. Rafal Ohme, and Dr. Cristina De Balanzo for a Warc Webinar about the “Latest Thinking on Implicit Testing.” Dr Reid discussed implicit concept testing and three keys to broader adoption of consumer neuroscience: sound science, application awareness, and market validation.
New Drug Opportunity Assessments Strat Planning For Future SuccessPharmacision LLC
Pharmaceutical Business Development, Marketing and Strategic Planning Groups need an early read on opportunities, but oftentimes don’t have time or budget for extensive market research.
Pharmacision presents a step by step opportunity assessment and valuation process through a case study format.
Benefits of employing this process:
Quickly weed out projects with very low probability of commercial success,
Construct a framework for deeper dive assessments to validate and refine assumptions when greater market knowledge is needed before making go/no go decisions, Support clinical development and commercialization strategic planning, Reduce overall costs.
There is a second digital revolution being played out by consumers, driven by the rapid adoption of smartphones and connected devices. As with the initial growth of the internet, many companies are being slow to react and are potentially risking their future success. This paper is a survival guide
Beyond Scaling Up: Universal Access to Effective Malaria Prevention and Treat...IDS
This presentation was given at the 'Beyond Scaling Up: Pathways to Universal Access' workshop which was held at the Institute of Development Studies, Brighton on the 24-25 May, 2010. This event was co-sponsored by the Future Health Systems Research Programme Consortium and the STEPS Centre. Mehra presented on the work of the Malaria Consortium.
Littmann stethescope all models,littmann stethoscope buy online delhi/indiaSurgicals Shoppeseo
Skytech Medical is engaged in manufacturing and distribution of medical equipment and surgical instruments in India. The parent company Continental Surgical was established in 1954.An experienced and well-trained staff handles an extensive range of medical supplies, which can broadly be classified into the following categories :
Surgical Instruments and Equipments
Operating and Examination Tables and Lights
Stainless Steel Operating Room Furniture
Electro Medical Equipment used in Operating Room, Diagnostics, Imaging
Physiotherapy, Pathology Laboratories, Neonatology, Cardiac Care, etc.
Medical, Surgical and Laboratory Consumables
Powder Coated and Stainless Steel Hospital Furniture
Rehabilitation, Mobility and Personal Home Care Devices
Skytech Medical & Surgical Devices.
3617, Netaji Subhash Marg, Darya Ganj
New Delhi-110002, India
Tel:- 91-11-43528106
http://surgicalshoppe.co.in
surgicalshoppeseo@gmail.com
Keynote presentation by Tim Riesterer, Chief Strategy and Marketing Officer of Corporate Visions to the BMA Phoenix / Arizona Technology Council 5th Annual Marketing Technology Summit August 22, 2013.
Tim presented a powerful session that taught the audience how to be more effective presenters, marketers and sales people.
Tim Riesterer is responsible for leading the strategic direction of Corporate Visions in thought leadership, positioning and product development. Tim has more than 20 years experience in Marketing and Sales. Prior to joining Corporate Visions, Tim co-founded Customer Message Management, LLC (CMM Group), where he was CEO until it was acquired by Corporate Visions in 2008. Before CMM Group, Tim was CMO and VP of Strategic Services for Ventaso. Additionally Tim was President and CEO of Brady Marketing Group and has worked in marketing, communication and sales support for world-class technology manufacturers such as Rockwell Automation and GE Medical Systems.
Tim is co-author of Customer Message Management: Increasing Marketing’s Impact on Selling (Thomson/AMA) and Conversations that Win the Complex Sale: Using Power Messaging to Create More Opportunities, Differentiate Your Solution, and Close More Deals (McGraw Hill).
2. Healthcare is not serving
the patient...
I’m not sure what to recommend for OK, I’ll give it a try but I’ve
your increased pain... maybe you already tried so many
can try this new drug? different meds!
3. Big data... big deal
Power of secondary data lost if not used to change healthcare delivery
0 01
10
1 11 0 1 1 1 0 1
1 1
0 1 1
00 0 1 0
1
0 1
1
0 1 0
0
0 0 1 0
0 0 1
1 1
0
1
10
1 1 1 0 1 0 0 0
1
0
0 1
0 0
0
0 1 10 10 0 01
0
1
1 1 0
1 0 0
0 0
1 0 1
1
0 1
0
1
4. How can patient data be useful?
Ubiqi provides a structured experiment framework
DISEASE TRACKER PERSONALIZED
FEEDBACK
PASSIVE MOBILE/
DEVICE DATA
CLINICAL
EFFECTIVENESS
3RD PARTY DATA
Personal Discovery
Engine
ITERATE
5. We power “citizen science”
through n=1 experiments
A B BA
AA B B
BASELINE SAMPLE HYPOTHESES RANDOMIZATION OUTCOME
AGGREGATION
PATIENT: HEALTHCARE ORGANIZATIONS:
Identify triggers Understand patient behavior
Understand symptoms Analyze patient response
Compare therapies Compare therapies
Report side-effects Review safety data
6. Apply same framework across
multiple conditions
pain respiratory gastrointestinal
7. We create value for many
healthcare organizations
HEALTHCARE
PHARMA
IT (EMR)
PATIENT
PHARMACY
PHARMACY DISEASE
BENEFITS PROVIDERS
CHAINS MGMT
MGMT
PAYER
9. Addressable market is 63M
people in US alone
250M
AMERICANS COVERED BY HEALTH INSURANCE
125M
HAVE CHRONIC CONDITION
63M
BENEFIT FROM
SELF-MANAGING
OUR ADDRESSABLE MARKET
10. Ubiqi has a unique approach
ACTIONABLE INSIGHTS
UBIQI
GENOMERA
PROVIDER-DRIVEN PATIENT-DRIVEN
PROTOCOLS PROTOCOLS
STUDY
CURE
THE
RINGFUL
CARROT
HEALTH
CONDITION TRACKING
11. 30+ years of experience
in healthcare, technology,
and design
ADVISORS
ESTHER DYSON
Jacqueline Thong, CEO JAYANT PARTHASARATHY, PHD
CHRIS ADAMS, MBA, PHD
Anshuman Sharma, CTO EGILIUS SPIERINGS, MD, PHD
William Tang, Design Lead MATTHEW MAMET
12. We have strong results
Partnerships
From initial migraine minimum viable product:
18K+ patients
20% active for more than 6 months
Positive health outcomes
!
Paying customer
Partnerships
In discussion
13. Go-to-market approach
REPLICATE
MODEL FOR
BACK PAIN
REFINE
PRODUCT FOR SCALE PLATFORM
MIGRAINE - Prove utility beyond migraine
- Gather data
- Validate payer revenue model
REFINE PLATFORM
MIGRAINE - Prove clinical validity
MVP - Gather data
- Scale pharma model
- Evaluate payer interest
MINIMUM VIABLE PRODUCT
- Prove utility to patients
- Gather data
- Evaluate pharma interest
- Validate pharma revenue model
14. Payers are our key target;
first build credibility
2013 2014 2015 2016 2017
REVENUE $600K $4M $16M $45M $75M
PHARMA PILOTS
SCALE PHARMA MODEL
PAYER PILOTS
SCALE PAYER MODEL
15. Seeking guidance in
partnership development
and $700K 3%
3%
KEY USE OF FUNDS
FOR Q12013 - Q42013
9%
R&D
10%
Business development
COGS 55%
Admin
B2B Marketing 20%
User acquisition
16. We envision acquisition
by a payer or disease
management company
Disease management companies
Healthcare payers
17. Help us create this
alternative future!
I saw that when I do yoga AND take That’s great! Let’s
the new meds, my daily pain scores work together to make
are 20% lower! that even better.
18. Get insights. Better health.
Jacqueline Thong
co-founder / CEO
jacqueline@ubiqihealth.com
+1 617 794 2089
www.ubiqihealth.com
20. ROI to pharma
Example: Eli Lilly / Boehringer-Ingelheim’s Tradjenta
Revenues are $3.5B annually (2.3M pts)
Adherence is 50% for oral anti-diabetic medications
Estimated $1.75B revenue lost per year
250K patients enroll in Ubiqi
At $5 per patient per month
B-I PAYS UBIQI $1.25M (1 year)
10% of users get better results
25K patients increase adherence to 75%
B-I INCREASES REVENUES BY: +$47M (1 year)
21. ROI to payers
Example: Aetna has 16 million subscribers
8% have asthma, costs them $2500/pt
25% enroll in Ubiqi program: 320K subscribers
At $1 per member per month...
AETNA PAYS UBIQI $3.8M (1 year)
25% of users get better results
80K subscribers reduce ER visits, hospital visits, unnecessary
prescription meds, save $500 each/yr
AETNA SAVES: $40M (1 year)
22. Intellectual Property
Items we anticipate constitute defensible IP:
i) process of taking structured / unstructured data and extracting
feature sets that are disease-specific and map to clinical evidence;
ii) learning engine which allows user to construct personalized
experiments that they can run to create evidence;
iii) algorithm that makes suggestions on what pieces of an
experiment the user might want to choose to ensure success based
on base-line and crowd-sourced data;
iv) algorithm that aims to increase the information contained in
unstructured patient-reported data to have stronger mapping
between evidence and outcomes